Hope et al. [63] conducted a prospective multicenter single-arm open-label phase 3 imaging trial to evaluate the diagnostic efficacy of [68Ga]Ga-PSMA-PET/CT in 764 patients with intermediate-to-high-risk PCa. Here, FOLH1 is linked to posterior cortical atrophy.